Propoxyphene Articles
Xanodyne agrees to take propoxyphene off US market, on FDA urging
22 November 2010
Four drugmakers to pay $124 million for submission of false claims to USA’s Medicaid
20 October 2009
FDA panel says Darvon risks outweigh benefits
23 February 2009
US Public Citizen seeks Darvon ban
20 March 2006
aaiPharma 1st-qtr net loss rockets
5 July 2004
aaiPharma's Darvocet gains FDA approval
22 September 2003
aaiPharma swings to profit in first quarter
28 April 2003
Lilly sells pain drugs for $211.4 million
18 March 2002
Third-party payers lead Rx payments
5 May 1999
Mylan Receives Two Product Approvals
26 September 1994
MIGRAINE MARKET SET TO BLOSSOM
21 February 1994
DANGER OF PULLING HARMFUL DRUGS
1 November 1993
Showing 1-13 of 13 articles
- 1
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
